Copyright
©The Author(s) 2025.
World J Radiol. Jan 28, 2025; 17(1): 98618
Published online Jan 28, 2025. doi: 10.4329/wjr.v17.i1.98618
Published online Jan 28, 2025. doi: 10.4329/wjr.v17.i1.98618
Table 1 Overview of minimally invasive ablation techniques
Technique | Mechanism | Frequency range | Max temperature | Tumor types treated | Strengths | Limitations | Common complications |
Radiofrequency ablation | High-frequency currents to induce coagulative necrosis | 460-500 KHz | 100 °C | Adrenal gland, bone, breast, kidney, liver, lung, pancreas, thyroid | Oldest technique, low cost, minimal equipment | Requires conductivity, heat sink, less effective over time | Bleeding, pain, infection, tumor seeding, skin burns, post-RFA syndrome |
Microwave ablation | Electromagnetic waves to induce coagulative necrosis | 300 MHz-300 GHz | 150 °C | Adrenal gland, bone, breast, kidney, liver, lung, prostate, spleen, uterus | Higher temps quickly, no conductivity needed, multiple probes for larger ablation | Cables can burn patient, requires cooling, less precise | Bleeding, pain, infection, tumor seeding, skin burns, post-ablation syndrome |
Cryoablation | Extreme cold to induce cell death | N/A (cryogenic gases) | -196 °C | Bone, breast, kidney, liver, lung, prostate, skin | No heat, vessel occlusion, minimal damage to nearby tissues, multiple probes for larger ablation | Specialized gases needed, safety hazard with compressed gases | Infection, pain, bleeding, cryoshock, cryoreaction |
High-intensity focused ultrasound | High-intensity ultrasound to generate localized heat and necrosis | 0.8-3.5 MHz | Exceeds 60 °C rapidly | Bone, breast, desmoid, kidney, liver, pancreas, prostate, uterus | Non-invasive, high precision, lower risk of off-target damage | Requires anesthetics, affected by tissue echogenicity | Skin burn, pain, fistula, local edema, hyperpigmentation |
Histotripsy | Cavitation bubbles to mechanically disintegrate tumors | 250 KHz-6 MHz | N/A | Brain, breast, kidney, liver, muscle, pancreas, prostate, skin, thymus | Non-invasive, non-thermal, high precision, lowest risk of off-target damage | Requires anesthetics, affected by tissue echogenicity, experimental, low clinical data | Immune-mediated responses |
- Citation: Fazlollahi F, Makary MS. Precision oncology: The role of minimally-invasive ablation therapy in the management of solid organ tumors. World J Radiol 2025; 17(1): 98618
- URL: https://www.wjgnet.com/1949-8470/full/v17/i1/98618.htm
- DOI: https://dx.doi.org/10.4329/wjr.v17.i1.98618